BillionToOne, Inc. (BLLN) stock
BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$105.15−5.64 (-5.09%)
Close on Nov 13, 2026Market cap $4.96BP/E –Yield –
BillionToOne ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
BillionToOne's ebitda for the twelve months ending Sep 30, 2026 was $51.90M, up 5142.4% year over year. For fiscal 2025 it was $22.92M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.92M | – |
| FY2024 | Dec 31, 2024 | -$40.15M | – |
| FY2023 | Dec 31, 2023 | -$63.60M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $13.00M | +14.8% |
| Q2 FY2026 | Jun 30, 2026 | $7.33M | +6010.0% |
| Q1 FY2026 | Mar 31, 2026 | $19.57M | – |
| Q4 FY2025 | Dec 31, 2025 | $12.00M | – |
| Q3 FY2025 | Sep 30, 2025 | $11.33M | – |
| Q2 FY2025 | Jun 30, 2025 | $120.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$522.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.93M | – |
See a number that looks wrong?